Rising auto insurance Costs: A deep Dive into Treatment Expenses
Table of Contents
The Escalating Costs of Car Accident Treatment
The financial strain on auto insurance providers continues to intensify, primarily due to the increasing expenses associated with treating injuries sustained in vehicular accidents. Recent data reveals a critically important surge in thes costs,prompting a closer examination of the factors driving this trend.

According to a recent analysis of data from major non-life insurance companies, including Samsung Fire, Hyundai Marine, KB Insurance, and DB Insurance, the collective treatment costs for automotive accidents have jumped to ₩1.3 trillion, marking a 7.2% increase compared to the previous year. This substantial rise underscores the growing financial burden on insurers and, consequently, policyholders.
oriental Medicine’s Growing Role and Scrutiny
A particularly noteworthy aspect of this cost escalation is the disproportionate increase in treatment expenses related to oriental medicine. While conventional medical treatment costs saw a modest rise of 2.2%, oriental medicine treatment expenses surged by a staggering 8.6%, reaching approximately ₩1.32 trillion. This disparity has ignited debate and raised questions about the appropriateness and necessity of certain oriental medicine practices in auto accident recovery.
The number of patients seeking oriental medicine treatment has also seen a dramatic increase, climbing from 890,000 in 2021 to over 1 million last year. In contrast, the number of patients visiting conventional hospitals has steadily declined, from 870,000 in 2021 to 820,000 last year.
The average treatment cost per patient in oriental medicine has also increased significantly, exceeding ₩1,017,000, a substantial jump from previous years. This has led to concerns about potentially excessive or standardized treatment protocols, nonetheless of individual patient needs.
There are many unclear parts of the number of oriental medicine care compared to both medical treatment.
Dr. kyong-sik Insurance
Public Perception and Calls for Reform
Public sentiment appears to be shifting towards greater scrutiny of oriental medicine practices in auto accident claims. A recent survey conducted by the civic group With Consumers
revealed that a significant majority of respondents (75%) believe there is a need to limit standardized or excessive claims related to oriental medicine treatments.
Moreover, the survey indicated that 82% of respondents view inpatient treatment at medical institutions for minor car accidents negatively, and 62% recognize the increase in oriental medical treatment as a major contributor to rising auto insurance premiums and a broader social problem.
The Impact of System Adjustments
Interestingly, the introduction of a system improvement plan in 2023, requiring medical certificates every two weeks after the initial four weeks following an accident, initially led to a slight decrease (0.6%) in per capita treatment costs. Though,this effect proved to be short-lived,as costs rebounded last year. This suggests that the system is being circumvented, with hospitals reportedly issuing certificates repeatedly, negating the intended cost-saving benefits.
Looking Ahead: The Need for Stricter Screening
The escalating costs of auto insurance treatment, particularly within the realm of oriental medicine, necessitate a comprehensive review of current practices and regulations. Establishing clearer and more detailed screening criteria for treatment protocols could help curb excessive or unnecessary procedures, ultimately mitigating the financial burden on insurers and consumers alike. As the data clearly indicates, a proactive approach is essential to ensure the sustainability and affordability of auto insurance in the years to come.
Data analysis: Trends in Auto accident treatment Costs
The following table provides a detailed breakdown of the trends in auto accident treatment costs, comparing oriental medicine and conventional medical treatments over the past four years.
| division | 2021 | 2022 | 2023 | 2024 | ||||
|---|---|---|---|---|---|---|---|---|
| Level 12-14 | Level 12-14 | Year-on-Year Growth rate | Level 12-14 | Year-on-Year Growth Rate | Level 12-14 | Year-on-Year Growth Rate | ||
| Oriental Medicine | Personnel | 893,519 | 959,598 | 7.4% | 987,036 | 2.9% | 1,015,231 | 2.9% |
| Treatment (₩1,000) | 826,724,795 | 931,079,665 | 12.6% | 950,934,306 | 2.1% | 1,032,330,279 | 8.6% | |
| Per Capita (₩) | 925 | 970 | 4.9% | 963 | -0.7% | 1,017 | 5.5% | |
| Conventional Medicine | Personnel | 873,323 | 840,566 | -3.8% | 830,942 | -1.1% | 828,691 | -0.3% |
| Treatment (₩1,000) | 290,336,585 | 276,475,124 | -4.8% | 266,600,784 | -3.6% | 272,459,502 | 2.2% | |
| Per Capita (₩) | 332 | 329 | -1.1% | 321 | -2.5% | 329 | 2.5% | |
| Total | Personnel | 1,416,294 | 1,441,762 | 1.8% | 1,462,263 | 1.4% | 1,486,134 | 1.6% |
| Treatment (₩1,000) | 1,117,061,380 | 1,207,554,790 | 8.1% | 1,217,535,089 | 0.8% | 1,304,789,781 | 7.2% | |
| Per Capita (₩) | 789 | 838 | 6.2% | 833 | -0.6% | 878 | 5.4% | |
